{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T14:12:59Z","timestamp":1665065579571},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12029-019-00350-6","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T09:03:40Z","timestamp":1576659820000},"page":"106-112","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ACE Inhibitor Therapy Does Not Influence the Survival Outcomes of Patients with Colorectal Liver Metastases Following Liver Resection"],"prefix":"10.1007","volume":"52","author":[{"given":"Sudip","family":"Sanyal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Alabraba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussain","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adina","family":"Olaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhanny","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,18]]},"reference":[{"issue":"1","key":"350_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends\u2014an update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16\u201327.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"350_CR2","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/cncr.22448","volume":"109","author":"LC Cummings","year":"2007","unstructured":"Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109(4):718\u201326.","journal-title":"Cancer"},{"issue":"5","key":"350_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10585-015-9719-0","volume":"32","author":"LG van der Geest","year":"2015","unstructured":"van der Geest LG, Koopman M, Verhoef C, Elferink MA, de Wilt JH. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis. 2015;32(5):457\u201365.","journal-title":"Clin Exp Metastasis"},{"key":"350_CR4","first-page":"283","volume":"4","author":"GP Kanas","year":"2012","unstructured":"Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"350_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/jgh.12685","volume":"30","author":"P Landreau","year":"2015","unstructured":"Landreau P, Drouillard A, Launoy G, Ortega-Deballon P, Jooste V, Lepage C, et al. Incidence and survival in late liver metastases of colorectal cancer. J Gastroenterol Hepatol. 2015;30(1):82\u20135.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"350_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ctrv.2015.06.006","volume":"41","author":"R Adam","year":"2015","unstructured":"Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015;41(9):729\u201341.","journal-title":"Cancer Treat Rev"},{"issue":"16","key":"350_CR7","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1161\/CIRCULATIONAHA.104.528695","volume":"112","author":"H Peng","year":"2005","unstructured":"Peng H, Carretero OA, Vuljaj N, Liao T-D, Motivala A, Peterson EL, et al. Angiotensin-converting enzyme inhibitors: a new mechanism of action. Circulation. 2005;112(16):2436\u201345.","journal-title":"Circulation."},{"issue":"9123","key":"350_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","volume":"352","author":"AF Lever","year":"1998","unstructured":"Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet. 1998;352(9123):179\u201384.","journal-title":"Lancet"},{"issue":"11","key":"350_CR9","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1245\/s10434-015-4436-0","volume":"22","author":"A Miyajima","year":"2015","unstructured":"Miyajima A, Yazawa S, Kosaka T, Tanaka N, Shirotake S, Mizuno R, et al. Prognostic impact of renin\u2013angiotensin system blockade on renal cell carcinoma after surgery. Ann Surg Oncol. 2015;22(11):3751\u20139.","journal-title":"Ann Surg Oncol"},{"key":"350_CR10","doi-asserted-by":"publisher","unstructured":"Sun H, Li T, Zhuang R, Cai W, Zheng Y. Do renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: Evidence from a meta-analysis including 55 studies. Medicine (Baltimore). 2017;96(13):e6394. https:\/\/doi.org\/10.1097\/MD.0000000000006394.","DOI":"10.1097\/MD.0000000000006394"},{"issue":"11","key":"350_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nrc2945","volume":"10","author":"AJ George","year":"2010","unstructured":"George AJ, Thomas WG, Hannan RD. The renin\u2013angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer. 2010;10(11):745\u201359.","journal-title":"Nat Rev Cancer"},{"key":"350_CR12","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1038\/ncomms3516","volume":"4","author":"VP Chauhan","year":"2013","unstructured":"Chauhan VP, Martin JD, Liu H, Lacorre DA, Jain SR, Kozin SV, et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat Commun. 2013;4:2516.","journal-title":"Nat Commun"},{"key":"350_CR13","doi-asserted-by":"crossref","unstructured":"Murphy JE, Wo JY-L, Ferrone C, Jiang W, Yeap BY, Blaszkowsky LS, et al. TGF-B1 inhibition with losartan in combination with FOLFIRINOX (F-NOX) in locally advanced pancreatic cancer (LAPC): preliminary feasibility and R0 resection rates from a prospective phase II study. J Clin Oncol. 2017;35(4):386.","DOI":"10.1200\/JCO.2017.35.4_suppl.386"},{"issue":"19","key":"350_CR14","doi-asserted-by":"publisher","first-page":"5959","DOI":"10.1158\/1078-0432.CCR-17-0256","volume":"23","author":"H Liu","year":"2017","unstructured":"Liu H, Naxerova K, Pinter M, Incio J, Lee H, Shigeta K, et al. Use of angiotensin system inhibitors is associated with immune activation and longer survival in nonmetastatic pancreatic ductal adenocarcinoma. Clin Cancer Res. 2017;23(19):5959\u201369.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"350_CR15","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3892\/mco.2015.630","volume":"3","author":"H Osumi","year":"2015","unstructured":"Osumi H, Matsusaka S, Wakatsuki T, Suenaga M, Shinozaki E, Mizunuma N. Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients. Mol Clin Oncol. 2015;3(6):1295\u2013300.","journal-title":"Mol Clin Oncol"},{"issue":"6","key":"350_CR16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000337979","volume":"83","author":"ST Kim","year":"2012","unstructured":"Kim ST, Park KH, Oh SC, Seo JH, Kim JS, Shin SW, et al. How does inhibition of the renin-angiotensin system affect the prognosis of advanced gastric cancer patients receiving platinum-based chemotherapy? Oncology. 2012;83(6):354\u201360.","journal-title":"Oncology."},{"key":"350_CR17","doi-asserted-by":"publisher","first-page":"21359","DOI":"10.1038\/srep21359","volume":"6","author":"L Miao","year":"2016","unstructured":"Miao L, Chen W, Zhou L, Wan H, Gao B, Feng Y. Impact of angiotensin I-converting enzyme inhibitors and angiotensin II type-1 receptor blockers on survival of patients with NSCLC. Sci Rep. 2016;6:21359.","journal-title":"Sci Rep"},{"key":"350_CR18","volume-title":"The English indices of deprivation 2015","author":"T Smith","year":"2015","unstructured":"Smith T, Noble M, Noble S, Wright G, McLennan D, Plunkett E. The English indices of deprivation 2015. London: Department for Communities and Local Government; 2015."},{"key":"350_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijsu.2018.03.031","volume":"53","author":"H Boyd-Carson","year":"2018","unstructured":"Boyd-Carson H, Irving G, Navarro A, Cameron I, Gomez D, Group NHS. Anti-platelet therapy does not influence the outcome of patients undergoing hepatic resection for colorectal liver metastases, an observational study. Int J Surg. 2018;53:59\u201364.","journal-title":"Int J Surg"},{"issue":"2","key":"350_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1477-2574.2009.00127.x","volume":"12","author":"D Gomez","year":"2010","unstructured":"Gomez D, Morris-Stiff G, Toogood GJ, Lodge JPA, Prasad KR. Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases. HPB. 2010;12(2):84\u201393.","journal-title":"HPB."},{"issue":"9","key":"350_CR21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/hpb.12216","volume":"16","author":"D Gomez","year":"2014","unstructured":"Gomez D, Zaitoun AM, De Rosa A, Hossaini S, Beckingham IJ, Brooks A, et al. Critical review of the prognostic significance of pathological variables in patients undergoing resection for colorectal liver metastases. HPB. 2014;16(9):836\u201344.","journal-title":"HPB."},{"issue":"5","key":"350_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/jso.21103","volume":"98","author":"D Gomez","year":"2008","unstructured":"Gomez D, Morris-Stiff G, Wyatt J, Toogood GJ, Lodge JPA, Prasad KR. Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol. 2008;98(5):371\u20136.","journal-title":"J Surg Oncol"},{"issue":"11","key":"350_CR23","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/bjs.5820","volume":"94","author":"D Gomez","year":"2007","unstructured":"Gomez D, Malik H, Bonney G, Wong V, Toogood G, Lodge J, et al. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg. 2007;94(11):1395\u2013402.","journal-title":"Br J Surg"},{"issue":"1","key":"350_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1172\/JCI16645","volume":"112","author":"K Egami","year":"2003","unstructured":"Egami K, Murohara T, Shimada T, Sasaki K-I, Shintani S, Sugaya T, et al. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest. 2003;112(1):67\u201375.","journal-title":"J Clin Invest"},{"key":"350_CR25","doi-asserted-by":"crossref","unstructured":"Bodor C, Nagy JP, V\u00e9gh B, N\u00e9meth A, Jenei A, MirzaHosseini S, et al. Angiotensin II increases the permeability and PV-1 expression of endothelial cells. Am J Phys Cell Phys. 2012;302(1):C267\u201376.","DOI":"10.1152\/ajpcell.00138.2011"},{"issue":"6","key":"350_CR26","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.bbamcr.2016.03.010","volume":"1863","author":"E Oh","year":"2016","unstructured":"Oh E, Kim JY, Cho Y, An H, Lee N, Jo H, et al. Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial\u2013mesenchymal transition and promotes tumor growth and angiogenesis. Biochim Biophys Acta Mol Cell Res. 2016;1863(6):1071\u201381.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"2","key":"350_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3892\/ijo.2012.1499","volume":"41","author":"K Okamoto","year":"2012","unstructured":"Okamoto K, Tajima H, Nakanuma S, Sakai S, Makino I, Kinoshita J, et al. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1\/CXCR4 axis in intrahepatic cholangiocarcinoma. Int J Oncol. 2012;41(2):573\u201382.","journal-title":"Int J Oncol"},{"issue":"3","key":"350_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0014-5793(01)02377-8","volume":"495","author":"Y Fujimoto","year":"2001","unstructured":"Fujimoto Y, Sasaki T, Tsuchida A, Chayama K. Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett. 2001;495(3):197\u2013200.","journal-title":"FEBS Lett"},{"issue":"11","key":"350_CR29","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1158\/1535-7163.MCT-04-0295","volume":"4","author":"H Uemura","year":"2005","unstructured":"Uemura H, Ishiguro H, Nagashima Y, Sasaki T, Nakaigawa N, Hasumi H, et al. Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells. Mol Cancer Ther. 2005;4(11):1699\u2013709.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"350_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/carcin\/bgh324","volume":"26","author":"M Fujita","year":"2005","unstructured":"Fujita M, Hayashi I, Yamashina S, Fukamizu A, Itoman M, Majima M. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis. 2005;26(2):271\u20139.","journal-title":"Carcinogenesis."},{"issue":"15","key":"350_CR31","first-page":"4176","volume":"62","author":"A Miyajima","year":"2002","unstructured":"Miyajima A, Kosaka T, Asano T, Asano T, Seta K, Kawai T, et al. Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis. Cancer Res. 2002;62(15):4176\u20139.","journal-title":"Cancer Res"},{"issue":"2","key":"350_CR32","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0006-291X(02)00496-5","volume":"294","author":"M Fujita","year":"2002","unstructured":"Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun. 2002;294(2):441\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"350_CR33","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.4161\/cbt.6.8.4412","volume":"6","author":"S Carl-McGrath","year":"2007","unstructured":"Carl-McGrath S, Ebert MP, Lendeckel U, Rocken C. Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread. Cancer Biol Ther. 2007;6(8):1229\u201337.","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"350_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10549-005-9091-x","volume":"97","author":"JP Fryzek","year":"2006","unstructured":"Fryzek JP, Poulsen AH, Lipworth L, Pedersen L, N\u00f8rgaard M, McLaughlin JK, et al. A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat. 2006;97(3):231\u20136.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"350_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.amjcard.2011.03.038","volume":"108","author":"I Sipahi","year":"2011","unstructured":"Sipahi I, Chou J, Mishra P, Debanne SM, Simon DI, Fang JC. Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk. Am J Cardiol. 2011;108(2):294\u2013301.","journal-title":"Am J Cardiol"},{"issue":"4","key":"350_CR36","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1440-1746.2006.04797.x","volume":"22","author":"JH Neo","year":"2007","unstructured":"Neo JH, Malcontenti-Wilson C, Muralidharan V, Christophi C. Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases. J Gastroenterol Hepatol. 2007;22(4):577\u201384.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"350_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2407-10-134","volume":"10","author":"JH Neo","year":"2010","unstructured":"Neo JH, Ager EI, Angus PW, Zhu J, Herath CB, Christophi C. Changes in the renin angiotensin system during the development of colorectal cancer liver metastases. BMC Cancer. 2010;10(1):134.","journal-title":"BMC Cancer"},{"issue":"8","key":"350_CR38","doi-asserted-by":"publisher","first-page":"720","DOI":"10.4161\/cbt.25092","volume":"14","author":"SW Wen","year":"2013","unstructured":"Wen SW, Ager EI, Neo J, Christophi C. The renin angiotensin system regulates Kupffer cells in colorectal liver metastases. Cancer Biol Ther. 2013;14(8):720\u20137.","journal-title":"Cancer Biol Ther"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-019-00350-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-019-00350-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-019-00350-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T13:05:33Z","timestamp":1628600733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-019-00350-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,18]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["350"],"URL":"https:\/\/doi.org\/10.1007\/s12029-019-00350-6","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,18]]},"assertion":[{"value":"18 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors confirm that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}